Dr. Courtney D. DiNardo of the University of Texas MD Anderson Cancer Center presents on the following learning objectives:

• Understanding the role of genetic testing on patient outcomes for HM patients

• Learning the prevalence of pathogenic germline variants in HM patients

• Gaining tools on how to suspect and diagnose hereditary HM

• How to manage hereditary HM patients and their at-risk family

This webinar took place on May 23rd and May 25th, 2022, and both of the Q&A sessions with expert panelists held after each presentation are included in this video:

May 23rd

Dr. Amy DeZern: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

Dr. Michael Savona: Vanderbilt-Ingram Cancer Center. Vanderbilt University School of Medicine

May 25th

Dr. Yasmin Abaza: Northwestern University, Feinberg School of Medicine

Dr. Kelly Bolton: Washington University School of Medicine

Dr. Elizabeth Griffiths: Roswell Park Comprehensive Cancer Center, SUNY at Buffalo

This event is intended for healthcare professionals who care for patients with hematologic malignancies.